FDA clears Xact Robotics remote control unit
11 Oct 2022
The remote control unit allows users to robotically insert and steer the Xact ACE robotic system. They can do so remotely from the control room.
Hingham, Massachusetts-based Xact Robotics designed the first-of-its-kind feature for CT-guided percutaneous procedures. The aim is to improve workflows while limiting exposure to radiation and reducing physical strain.
“The XACT ACE Robotic System has already allowed users to make percutaneous procedures, such as ablations, drainages and biopsies, more accurate, consistent and efficient,” said Shai Meltzer, CEO of Xact Robotics. “The addition of ACE Xtend has the potential to further increase efficiencies for the care team with a streamlined workflow that helps reduce the time in which physicians and other users are exposed to harmful radiation during standard procedures.”
Xact Robotics said its ACE system marks the first and only technology that combines image-based planning and monitoring. It uses patented S-Drive technology. S-Drive enables the system to quickly adapt from a linear to a non-linear trajectory. This happens through robotic insertion and steering of instruments during interventional percutaneous procedures.
The company said it precisely delivers instruments to designated targets. It does so with “unparalleled accuracy, unmatched consistency, and unlimited efficiency,” Xact says. Data shows 1.7mm tip-to-target average accuracy upon first insertion.
“Interventional radiology is among the medical specialties that are facing a physician shortage in the coming years and technologies that can improve their efficiencies are crucial,” said Dr. Jeffrey Solomon VP of medical affairs at Xact. “By equipping different users with tools that can standardize the procedure and potentially shorten procedure times, we can maximize the number of patients they see and help to mitigate the gap between the patient population and the physician population.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.